Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 802 results for "fusion iii"

Rigaku Publishes New Method for Silicate Rock Analysis by Fusion Using Rigaku ZSX Primus III+ WDXRF
AZoM

Rigaku Publishes New Method for Silicate Rock Analysis by Fusi...

Rigaku Corporation today announced a new method for silicate rock analysis by wavelength dispersive X-ray fluorescence (WDXRF) spectrometry. Rigaku Application Note XRF 1019 demonstrates the low dilution fusion method to determine chemical ... Fat Pitch Financials, 2 weeks ago
[x]  

4 images for fusion iii

Virtual Strategy Magazine, 2 weeks ago
AZoM, 2 weeks ago
Diagnostic Imaging, 2 months ago
Investing.com, 2 months ago

4 images for fusion iii

Logo
Virtual Strategy Magazine, 2 weeks ago
Asian Journal

A fusion of two cultures: International chef Cocoy Ventura offers a Pinoy twist on an American tradition

| No Comments In celebration of Thanksgiving Day on Nov. 27, the Asian Journal requested Chef Cornelio Cocoy Ventura III to prepare a feast, featuring recipes that infuse Filipino flavors, reminiscent of dishes enjoyed during other holidays back ...
 Asian Journal1 month ago

Misys increases its dominance in the 2014 Risk Technology Rankings as the overall winner in enterprise-wide risk management

Overall winner for market, credit, counterparty, liquidity, aggregation and Basel III and first place in eight other categories Misys, the global leader in financial services software, has been honoured with the overall winner in the enterprise-wide ...
 PRWeb2 weeks ago
[x]  
Yahoo! Finance

Autodesk Reinvents Teamwork In The ...

Autodesk, Inc. (NASDAQ: ADSK) cloud-based tools like A360 and Fusion 360 empower designers and engineers to work in whole new ways and are reinventing the modern design and collaboration experience. At Autodesk University in Las Vegas, the company ...
 EFYTimes.com3 weeks ago AUTODESK : Reinvents Teamwork in the Cloud  4 Traders3 weeks ago
[x]  

Thoratec: At The Heart Of A Health-Related Investment Strategy

Summary Thoratec is facing headwinds in NYHA Class IV Heart Failure, and is becalmed in Class III. Although there exists a large untapped market for mechanical heart assist devices in late stage heart failure management, this market is proving ...
 Seeking Alpha3 weeks ago
AndhraNews.net

Novartis presents results from four pivotal Phase III studies for investigational drug secukinumab (AIN457) in psoriatic arthritis and ankylosing spondylitis at ACR 2014

Canada NewsWire DORVAL, QC, Nov. 17, 2014 DORVAL, QC The abstracts include data from two pivotal Phase III studies, FUTURE 1 and FUTURE 2 in PsA patients and two pivotal Phase III studies, MEASURE 1 and MEASURE 2, in patients with AS. All ...
 Digital Journal1 month ago Novartis presents positive results from phase III studies of AIN457 in ankylosing spondylitis at ACR Congress  PharmaBiz1 month ago Novartis AIN457 (secukinumab) showed significant symptom improvement in two pivotal Phase III ankylosing spondylitis studies  Franklin Credit Management Corporation1 month ago Novartis presents ground-breaking Phase III results showing AIN457 (secukinumab) significant efficacy in ankylosing spondylitis patients  SPi World News1 month ago
[x]  

Effect of the RET Inhibitor Vandetanib in a Patient With RET Fusion-Positive Metastatic Non-Small-Cell Lung Cancer [Diagnosis in Oncology]

Here we report prolonged antitumor activity in a patient with a known RET-rearranged NSCLC who was treated with the RET inhibitor vandetanib. Specifically, our patient had a CCDC6-RET fusion RET rearrangement and experienced a 76% decrease in tumor ...
 Journal of Clinical Oncology1 month ago
Digital Journal

CSL : Behring Submits Biologics License Application for FDA Approval of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant...

CSL Behring Submits Biologics License Application for FDA Approval of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin rIX-FP for Hemophilia B Patients By a News Reporter-Staff News Editor at Biotech Week -- CSL ...
 4 Traders1 day ago CSL Behring Submits Biologics License Application for FDA Approval of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) for Hemophilia B Patients  Digital Journal1 week ago
[x]  

Bone Therapeutics and Kasios to Collaborate on Novel Product for the Optimisation of Spinal Fusion Procedures

Companies to develop a novel product combining ' cell therapy product ALLOB®with Kasios's synthetic bone substitute BONE THERAPEUTICS, the regenerative therapy company addressing unmet medical needs in the fields of bone diseases and orthopaedics ...
 Wall Street Business Network1 month ago Bone Therapeutics & Collaborate On Novel Product For Optimisation Of Spinal Fusion Procedures  BioSpace1 month ago Bone Therapeutics and Kasios Form Product Development Partnership  ODT Mag4 weeks ago
[x]  

ORACLE : Evosys Teams With Qatar Cool and Oracle to Go-live With First ECEMEA Oracle Fusion ERP Implementation in the Cloud

Evosys, a leading Oracle Platinum Partner, announced the first successful implementation of Cloud solutions, namely Oracle Fusion ERP, Fusion HCM, Payroll and Taleo Suite for Qatar Cool, in the entire ECEMEA region, thus becoming the pioneer in the ...
 4 Traders1 month ago Evosys Teams With Qatar Cool and Oracle to Go-live With First ECEMEA Oracle Fusion ERP Implementation in the Cloud  Franklin Credit Management Corporation1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less